Rachana Agarwal

Title: Rachana Agarwal: Innovator in Gastric Cancer Diagnosis and Treatment

Introduction

Rachana Agarwal is a prominent inventor based in Ellicott City, MD (US). She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of gastric cancer. Her innovative work has the potential to improve patient outcomes and advance the understanding of this serious disease.

Latest Patents

Rachana Agarwal holds a patent for "Methods and compositions for diagnosing and treating gastric cancer." This invention provides methods and compositions that aid in the diagnosis and treatment of gastric cancer. Specifically, the method involves diagnosing gastric cancer or assessing the likelihood of its presence in a patient by measuring the methylation levels of specific biomarkers in a sample collected from the patient. If the biomarkers are found to be hypermethylated, it indicates a likelihood of gastric cancer. The biomarkers identified in her patent include tight junction protein claudin-1 (CLD-N11), transcription factor BarH-like homeobox (BARX1), basonuclin1 (BNC1), and several others.

Career Highlights

Rachana Agarwal is affiliated with Johns Hopkins University, where she continues her research and development in the field of gastric cancer. Her work is characterized by a commitment to advancing medical science and improving diagnostic techniques.

Collaborations

Rachana has collaborated with Stephen J Meltzer, a fellow researcher in the field. Their partnership exemplifies the collaborative spirit of scientific research, which often leads to groundbreaking discoveries.

Conclusion

Rachana Agarwal's contributions to the field of gastric cancer diagnosis and treatment highlight her innovative spirit and dedication to improving healthcare. Her patent represents a significant advancement in medical research, and her work continues to inspire future innovations in the field.